Terms: = Brain cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
126 results:
1. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
2. Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g
Ganz PA; Bandos H; Španić T; Friedman S; Müller V; Kuemmel S; Delaloge S; Brain E; Toi M; Yamauchi H; de Dueñas EM; Armstrong A; Im SA; Song CG; Zheng H; Sarosiek T; Sharma P; Geng C; Fu P; Rhiem K; Frauchiger-Heuer H; Wimberger P; t'Kint de Roodenbeke D; Liao N; Goodwin A; Chakiba-Brugère C; Friedlander M; Lee KS; Giacchetti S; Takano T; Henao-Carrasco F; Virani S; Valdes-Albini F; Domchek SM; Bane C; McCarron EC; Mita M; Rossi G; Rastogi P; Fielding A; Gelber RD; Scheepers ED; Cameron D; Garber J; Geyer CE; Tutt ANJ
J Clin Oncol; 2024 Apr; 42(11):1288-1300. PubMed ID: 38301187
[TBL] [Abstract] [Full Text] [Related]
3. Cerebellar metastasis of ovarian cancer: a case report.
Cabitza E; Pirola M; Baldessari C; Bernardelli G; Zunarelli E; Pipitone S; Vitale MG; Nasso C; Molinaro E; Oltrecolli M; D'Agostino E; Mandato VD; Palicelli A; Dominici M; Sabbatini R
J Med Case Rep; 2023 Dec; 17(1):553. PubMed ID: 38115068
[TBL] [Abstract] [Full Text] [Related]
4. Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
Grob ST; Miller KR; Sanford B; Donson AM; Jones K; Griesinger AM; Amani V; Foreman NK; Liu A; Handler M; Hankinson TC; Milgrom S; Levy JMM
J Neurooncol; 2023 Oct; 165(1):161-169. PubMed ID: 37878192
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of a planar diode matrix for SRS patient-specific QA in comparison with GAFchromic films.
Infusino E; Ianiro A; Luppino S; Nocentini S; Pugliatti C; Soriani A
J Appl Clin Med Phys; 2023 Aug; 24(8):e13947. PubMed ID: 37408167
[TBL] [Abstract] [Full Text] [Related]
6. Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.
Sung C; An J; Lee S; Park J; Lee KS; Kim IH; Han JY; Park YH; Kim JH; Kang EJ; Hong MH; Kim TY; Lee JC; Lee JL; Yoon S; Choi CM; Lee DH; Yoo C; Kim SW; Jeong JH; Seo S; Kim SY; Kong SY; Choi JK; Park SR
Nat Cancer; 2023 Jun; 4(6):844-859. PubMed ID: 37308678
[TBL] [Abstract] [Full Text] [Related]
7. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
8. Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy.
Kinslow CJ; Mercurio A; Kumar P; Rae AI; Siegelin MD; Grinband J; Taparra K; Upadhyayula PS; McKhann GM; Sisti MB; Bruce JN; Canoll PD; Iwamoto FM; Kachnic LA; Yu JB; Cheng SK; Wang TJC
JAMA Oncol; 2023 Jul; 9(7):919-927. PubMed ID: 37200021
[TBL] [Abstract] [Full Text] [Related]
9. Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian cancer.
Kim YN; Shim Y; Seo J; Choi Z; Lee YJ; Shin S; Kim SW; Kim S; Choi JR; Lee JY; Lee ST
Clin Cancer Res; 2023 Jul; 29(14):2725-2734. PubMed ID: 37067525
[TBL] [Abstract] [Full Text] [Related]
10. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
11. The BRCAness Landscape of cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
12. Retrotransposon instability dominates the acquired mutation landscape of mouse induced pluripotent stem cells.
Gerdes P; Lim SM; Ewing AD; Larcombe MR; Chan D; Sanchez-Luque FJ; Walker L; Carleton AL; James C; Knaupp AS; Carreira PE; Nefzger CM; Lister R; Richardson SR; Polo JM; Faulkner GJ
Nat Commun; 2022 Dec; 13(1):7470. PubMed ID: 36463236
[TBL] [Abstract] [Full Text] [Related]
13. Stellettin B Sensitizes Glioblastoma to DNA-Damaging treatments by Suppressing PI3K-Mediated Homologous Recombination Repair.
Peng X; Zhang S; Wang Y; Zhou Z; Yu Z; Zhong Z; Zhang L; Chen ZS; Claret FX; Elkabets M; Wang F; Sun F; Wang R; Liang H; Lin HW; Kong D
Adv Sci (Weinh); 2023 Jan; 10(3):e2205529. PubMed ID: 36453577
[TBL] [Abstract] [Full Text] [Related]
14. Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia.
Widiasari NPA; Rai IBN; Dwi Kusumawardani IAJ; Sajinadiyasa IGK; Candrawati NW; Arisanti NLPE
Rom J Intern Med; 2023 Mar; 61(1):63-71. PubMed ID: 36453446
[No Abstract] [Full Text] [Related]
15. Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells.
Kalpongnukul N; Bootsri R; Wongkongkathep P; Kaewsapsak P; Ariyachet C; Pisitkun T; Chantaravisoot N
J Proteome Res; 2022 Dec; 21(12):2893-2904. PubMed ID: 36315652
[TBL] [Abstract] [Full Text] [Related]
16. Central vs site outcome adjudication in the iris trial.
Forman R; Viscoli CM; Bath PM; Furie KL; Guarino P; Inzucchi SE; Young L; Kernan WN
J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106667. PubMed ID: 35901589
[TBL] [Abstract] [Full Text] [Related]
17. ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair.
Jiao W; Zhu S; Shao J; Zhang X; Xu Y; Zhang Y; Wang R; Zhong Y; Kong D
Biomed Res Int; 2022; 2022():8568528. PubMed ID: 35872860
[TBL] [Abstract] [Full Text] [Related]
18. The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
Palmisciano P; Haider AS; Balasubramanian K; D'Amico RS; Wernicke AG
J Neurooncol; 2022 Aug; 159(1):117-133. PubMed ID: 35696019
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse.
Dobosz P; Stempor PA; Ramírez Moreno M; Bulgakova NA
Heredity (Edinb); 2022 Jul; 129(1):64-74. PubMed ID: 35459932
[TBL] [Abstract] [Full Text] [Related]
20. Implementing and evaluating a high-resolution diode array for patient-specific quality assurance of robotic brain stereotactic radiosurgery/radiotherapy.
Xu Q; Huynh K; Nie W; Rose MS; Chawla AK; Choe KS; Kanani S; Kubicek GJ; Fan J
J Appl Clin Med Phys; 2022 May; 23(5):e13569. PubMed ID: 35278033
[TBL] [Abstract] [Full Text] [Related]
[Next]
